Design and formulation of fast-dissolving microneedles for the rapid transdermal delivery of lorazepam

< .05), confirming efficient systemic delivery of lorazepam. These findings highlight LMNs as a rapid-acting, non-invasive transdermal drug delivery system for managing status epilepticus, particularly in ambulatory care settings.